Report

1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 31
1.2.1 INCLUSIONS & EXCLUSIONS 32
1.3 MARKET SCOPE 33
1.3.1 BIOACTIVE DRESSINGS MARKET SEGMENTATION 33
1.3.2 YEARS CONSIDERED 34
1.4 CURRENCY CONSIDERED 34
1.5 STAKEHOLDERS 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY DATA 37
2.1.2.1 Primary sources 37
2.1.2.2 Key data from primary sources 38
2.1.2.3 Key industry insights 39
2.1.2.4 Breakdown of primary interviews 39
2.2 MARKET SIZE ESTIMATION 40
2.2.1 BOTTOM-UP APPROACH 40
2.2.1.1 Approach 1: Company revenue estimation approach 41
2.2.1.2 Approach 3: Presentations of companies and primary interviews 41
2.2.1.3 Growth forecast 41
2.2.1.4 CAGR projections 42
2.2.2 TOP-DOWN APPROACH 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
2.4 STUDY ASSUMPTIONS 45
2.4.1 GROWTH RATE ASSUMPTIONS 45
2.4.2 LIMITATIONS 45
2.5 RISK ASSESSMENT 46
3 EXECUTIVE SUMMARY 47
4 PREMIUM INSIGHTS 51
4.1 BIOACTIVE DRESSINGS MARKET OVERVIEW 51
4.2 BIOACTIVE DRESSINGS MARKET SHARE, BY PRODUCT, 2024 VS. 2029 52
4.3 BIOACTIVE DRESSINGS MARKET SHARE, BY TYPE, 2024 VS. 2029 52
4.4 SKIN SUBSTITUTES MARKET SHARE, BY TYPE, 2024 VS. 2029 53
4.5 BIOACTIVE DRESSINGS MARKET SHARE, BY PROPERTY TYPE, 2024 VS. 2029 53
4.6 BIOACTIVE DRESSINGS MARKET SHARE, BY APPLICATION, 2024 VS. 2029 54
4.7 BIOACTIVE DRESSINGS MARKET SHARE FOR CHRONIC WOUNDS,
BY TYPE, 2024 VS. 2029 54
4.8 BIOACTIVE DRESSINGS MARKET SHARE FOR ACUTE WOUNDS, BY TYPE, 2024 VS. 2029 55
4.9 BIOACTIVE DRESSINGS MARKET SHARE, BY END USER, 2024 VS. 2029 55
4.10 BIOACTIVE DRESSINGS MARKET SHARE FOR HOSPITALS & CLINICS,
BY TYPE, 2024 VS. 2029 56
4.11 BIOACTIVE DRESSINGS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
5.2.1 DRIVERS 58
5.2.1.1 Rising prevalence of chronic wounds 58
5.2.1.2 Growing geriatric population 58
5.2.1.3 Increasing number of surgical procedures worldwide 59
5.2.1.4 Increasing incidence of burn injuries 60
5.2.1.5 Advancements in bioactive dressing technology 60
5.2.2 RESTRAINTS 61
5.2.2.1 High costs of bioactive dressing products 61
5.2.2.2 Limited reimbursement policies 61
5.2.3 OPPORTUNITIES 62
5.2.3.1 Growth potential of emerging countries 62
5.2.3.2 New product development 62
5.2.3.3 Strategic collaboration between market players 63
5.2.4 CHALLENGES 64
5.2.4.1 Difficult regulatory approval process 64
5.2.4.2 Lack of awareness and education 64
5.3 PRICING ANALYSIS 65
5.3.1 AVERAGE SELLING PRICE TREND OF BIOACTIVE DRESSINGS 65
5.3.2 AVERAGE SELLING PRICE OF BIOACTIVE DRESSINGS, BY REGION 66
5.4 PATENT ANALYSIS 67
5.4.1 LIST OF MAJOR PATENTS 68
5.5 VALUE CHAIN ANALYSIS 69
5.6 SUPPLY CHAIN ANALYSIS 70
5.7 ECOSYSTEM ANALYSIS 72
5.7.1 BIOACTIVE DRESSINGS MARKET: ROLE IN ECOSYSTEM 73
5.8 PORTER'S FIVE FORCES ANALYSIS 74
5.8.1 THREAT OF NEW ENTRANTS 75
5.8.2 THREAT OF SUBSTITUTES 75
5.8.3 BARGAINING POWER OF BUYERS 75
5.8.4 BARGAINING POWER OF SUPPLIERS 75
5.8.5 DEGREE OF COMPETITION 75
5.9 KEY STAKEHOLDERS & BUYING CRITERIA 76
5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS 76
5.9.2 BUYING CRITERIA 76
5.10 REGULATORY ANALYSIS 77
5.10.1 REGULATORY LANDSCAPE 77
5.10.1.1 North America 77
5.10.1.1.1 US 77
5.10.1.1.2 Canada 77
5.10.1.2 Europe 78
5.10.1.3 Asia Pacific 78
5.10.1.3.1 China 78
5.10.1.3.2 Japan 78
5.10.1.3.3 India 78
5.10.1.4 Latin America 78
5.10.1.4.1 Brazil 79
5.10.1.4.2 Mexico 79
5.10.1.5 Middle East 79
5.10.1.6 Africa 79
5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 80
5.11 TRADE ANALYSIS 81
5.11.1 TRADE ANALYSIS FOR WADDING, GAUZE, AND BANDAGES 81
5.12 TECHNOLOGY ANALYSIS 83
5.12.1 KEY TECHNOLOGIES 83
5.12.1.1 Kollagen technology 83
5.12.2 COMPLEMENTARY TECHNOLOGIES 83
5.12.2.1 Bioactive microfiber gelling technology 83
5.12.3 ADJACENT TECHNOLOGIES 84
5.12.3.1 Kerecis intact fish skin technology 84
5.13 KEY CONFERENCES & EVENTS, 2024-2025 84
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 86
5.15 INVESTMENT & FUNDING SCENARIO 87
5.16 IMPACT OF AI ON BIOACTIVE DRESSINGS MARKET 87
6 BIOACTIVE DRESSINGS MARKET, BY PRODUCT 89
6.1 INTRODUCTION 90
6.2 BIOACTIVE DRESSINGS 90
6.2.1 COLLAGEN DRESSINGS 93
6.2.1.1 Unique healing properties and biocompatibility to drive growth 93
?
6.2.2 ALGINATE DRESSINGS 96
6.2.2.1 Excellent absorption capacity to boost demand for alginate dressings 96
6.2.3 CHITOSAN DRESSINGS 99
6.2.3.1 Rising need for effective, natural wound healing options to
support market growth 99
6.2.4 HONEY DRESSINGS 101
6.2.4.1 Effective and natural wound care management to fuel growth 101
6.2.5 OTHER BIOACTIVE DRESSINGS 104
6.3 SKIN SUBSTITUTES 107
6.3.1 HUMAN DONOR TISSUE-DERIVED PRODUCTS 110
6.3.1.1 High efficacy of human donor tissue-derived products to support market demand 110
6.3.2 ACELLULAR ANIMAL-DERIVED PRODUCTS 113
6.3.2.1 Recognition of importance of ECM in wound treatment to boost development of acellular wound care biologics 113
6.3.3 BIOSYNTHETIC PRODUCTS 116
6.3.3.1 Increased bioburden of infected wounds to stimulate market growth 116
7 BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE 119
7.1 INTRODUCTION 120
7.2 NON-ANTIMICROBIAL DRESSINGS 120
7.2.1 COST-EFFECTIVENESS COMPARED TO ANTIMICROBIAL DRESSINGS TO BOOST MARKET 120
7.3 ANTIMICROBIAL DRESSINGS 123
7.3.1 EFFECTIVENESS IN PREVENTING AND MANAGING INFECTIONS TO
DRIVE GROWTH 123
8 BIOACTIVE DRESSINGS MARKET, BY APPLICATION 127
8.1 INTRODUCTION 128
8.2 CHRONIC WOUNDS 128
8.2.1 DIABETIC FOOT ULCERS 131
8.2.1.1 Increasing prevalence of diabetes to drive growth 131
8.2.2 PRESSURE ULCERS 135
8.2.2.1 Growing geriatric population to drive demand for bioactive dressings 135
8.2.3 VENOUS LEG ULCERS 138
8.2.3.1 Rising prevalence of obesity to boost adoption 138
8.2.4 OTHER CHRONIC WOUNDS 141
8.3 ACUTE WOUNDS 143
8.3.1 SURGICAL WOUNDS 146
8.3.1.1 Rising volume of surgical procedures to support market growth 146
8.3.2 TRAUMATIC WOUNDS 149
8.3.2.1 Increasing number of road accidents to drive growth 149
8.3.3 BURNS 152
8.3.3.1 High incidence of burn injuries to propel market growth 152
9 BIOACTIVE DRESSINGS MARKET, BY END USER 156
9.1 INTRODUCTION 157
9.2 HOSPITALS & CLINICS 157
9.2.1 INPATIENT SETTINGS 161
9.2.1.1 Increasing hospital admissions due to HAIs to drive growth 161
9.2.2 OUTPATIENT SETTINGS 164
9.2.2.1 Rising costs of inpatient facilities to drive demand for
outpatient care settings 164
9.3 HOME CARE SETTINGS 167
9.3.1 LOW COSTS AND CONVENIENCE TO DRIVE GROWTH 167
9.4 LONG-TERM CARE FACILITIES 170
9.4.1 GROWTH IN GERIATRIC & VULNERABLE POPULATIONS TO BOOST DEMAND FOR BETTER LONG-TERM CARE 170
9.5 OTHER END USERS 173
10 BIOACTIVE DRESSINGS MARKET, BY REGION 177
10.1 INTRODUCTIONS 178
10.2 NORTH AMERICA 178
10.2.1 US 184
10.2.1.1 Rising prevalence of chronic diseases to drive market 184
10.2.2 CANADA 187
10.2.2.1 Growing awareness about diabetes and its associated complications to fuel market 187
10.3 EUROPE 192
10.3.1 GERMANY 196
10.3.1.1 Rising focus on medical technology clusters to boost market 196
10.3.2 UK 200
10.3.2.1 Increasing prevalence of surgeries to aid growth 200
10.3.3 FRANCE 204
10.3.3.1 Surge in elderly population to propel market 204
10.3.4 ITALY 208
10.3.4.1 Improved life expectancy to support growth 208
10.3.5 SPAIN 211
10.3.5.1 Increasing median age to augment growth 211
10.3.6 REST OF EUROPE 215
10.4 ASIA PACIFIC 218
10.4.1 CHINA 223
10.4.1.1 Growing incidence of diabetic foot ulceration to drive market 223
10.4.2 JAPAN 227
10.4.2.1 Expanding hospital infrastructure to fuel market 227
10.4.3 INDIA 230
10.4.3.1 Booming medical tourism in India to boost market 230
10.4.4 REST OF ASIA PACIFIC 234
10.5 LATIN AMERICA 238
10.5.1 BRAZIL 242
10.5.1.1 Presence of large patient population to stimulate growth 242
10.5.2 MEXICO 245
10.5.2.1 Growing awareness about effective wound care approaches to support growth 245
10.5.3 REST OF LATIN AMERICA 249
10.6 MIDDLE EAST & AFRICA 252
10.6.1 GROWING DEMAND FOR HEALTHCARE FACILITIES TO AID MARKET GROWTH 252
10.7 GCC COUNTRIES 256
10.7.1 FAVORABLE HEALTHCARE INFRASTRUCTURE AND INITIATIVES
TO BOOST MARKET 256
11 COMPETITIVE LANDSCAPE 260
11.1 OVERVIEW 260
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN 260
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BIOACTIVE DRESSINGS MARKET 261
11.3 REVENUE ANALYSIS 263
11.4 MARKET SHARE ANALYSIS 264
11.4.1 RANKING OF KEY MARKET PLAYERS 265
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 266
11.5.1 STARS 266
11.5.2 EMERGING LEADERS 266
11.5.3 PERVASIVE PLAYERS 266
11.5.4 PARTICIPANTS 266
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 268
11.5.5.1 Company footprint 268
11.5.5.2 Product footprint 268
11.5.5.3 Property footprint 268
11.5.5.4 Application footprint 269
11.5.5.5 Region footprint 269
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 269
11.6.1 PROGRESSIVE COMPANIES 269
11.6.2 RESPONSIVE COMPANIES 270
11.6.3 DYNAMIC COMPANIES 270
11.6.4 STARTING BLOCKS 270
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 272
11.7 COMPANY VALUATION & FINANCIAL METRICS 273
11.7.1 FINANCIAL METRICS 273
11.7.2 COMPANY VALUATION 273
11.8 BRAND/PRODUCT COMPARISON 274
?
11.9 COMPETITIVE SCENARIO 274
11.9.1 PRODUCT LAUNCHES AND APPROVALS 274
11.9.2 DEALS 275
11.9.3 EXPANSIONS 276
11.9.4 OTHER DEVELOPMENTS 276
12 COMPANY PROFILES 277
12.1 KEY PLAYERS 277
12.1.1 SMITH+NEPHEW 277
12.1.1.1 Business overview 277
12.1.1.2 Products offered 278
12.1.1.3 Recent developments 279
12.1.1.3.1 Expansions 279
12.1.1.3.2 Other developments 280
12.1.1.4 MnM view 280
12.1.1.4.1 Key strengths 280
12.1.1.4.2 Strategic choices 280
12.1.1.4.3 Weaknesses and competitive threats 280
12.1.2 ORGANOGENESIS INC. 281
12.1.2.1 Business overview 281
12.1.2.2 Products offered 282
12.1.2.3 Recent developments 283
12.1.2.3.1 Product approvals 283
12.1.2.3.2 Other developments 284
12.1.2.4 MnM view 284
12.1.2.4.1 Key strengths 284
12.1.2.4.2 Strategic choices 284
12.1.2.4.3 Weaknesses and competitive threats 284
12.1.3 MIMEDX GROUP, INC. 285
12.1.3.1 Business overview 285
12.1.3.2 Products offered 286
12.1.3.3 Recent developments 287
12.1.3.3.1 Product launches and approvals 287
12.1.3.3.2 Deals 287
12.1.3.4 MnM view 288
12.1.3.4.1 Key strengths 288
12.1.3.4.2 Strategic choices 288
12.1.3.4.3 Weaknesses and competitive threats 288
12.1.4 3M 289
12.1.4.1 Business overview 289
12.1.4.2 Products offered 290
12.1.4.3 Recent developments 292
12.1.4.3.1 Other developments 292
12.1.4.4 MnM view 292
12.1.4.4.1 Key strengths 292
12.1.4.4.2 Strategic choices 292
12.1.4.4.3 Weaknesses and competitive threats 292
12.1.5 CARDINAL HEALTH 293
12.1.5.1 Business overview 293
12.1.5.2 Products offered 294
12.1.5.3 MnM view 295
12.1.5.3.1 Key strengths 295
12.1.5.3.2 Strategic choices 295
12.1.5.3.3 Weaknesses and competitive threats 296
12.1.6 B. BRAUN SE 297
12.1.6.1 Business overview 297
12.1.6.2 Products offered 299
12.1.7 MOLNLYCKE AB 300
12.1.7.1 Business overview 300
12.1.7.2 Products offered 301
12.1.8 CONVATEC INC. 302
12.1.8.1 Business overview 302
12.1.8.2 Products offered 303
12.1.8.3 Recent developments 305
12.1.8.3.1 Product approvals 305
12.1.8.3.2 Deals 305
12.1.9 PAUL HARTMANN AG 306
12.1.9.1 Business overview 306
12.1.9.2 Products offered 307
12.1.10 COLOPLAST CORP. 309
12.1.10.1 Business overview 309
12.1.10.2 Products offered 310
12.1.10.3 Recent developments 311
12.1.10.3.1 Deals 311
12.1.11 INTEGRA LIFESCIENCES CORPORATION 312
12.1.11.1 Business overview 312
12.1.11.2 Products offered 313
12.1.11.3 Recent developments 316
12.1.11.3.1 Deals 316
12.1.12 ESSITY AKTIEBOLAG 317
12.1.12.1 Business overview 317
12.1.12.2 Products offered 318
12.1.12.3 Recent developments 319
12.1.12.3.1 Product launches 319
12.1.12.3.2 Deals 319
12.1.13 COVALON TECHNOLOGIES LTD. 320
12.1.13.1 Business overview 320
12.1.13.2 Products offered 321
12.1.13.3 Recent developments 321
12.1.13.3.1 Other developments 321
12.1.14 SANARA MEDTECH 322
12.1.14.1 Business overview 322
12.1.14.2 Products offered 323
12.1.14.3 Recent developments 324
12.1.14.3.1 Product launches 324
12.1.14.3.2 Deals 324
12.2 OTHER PLAYERS 325
12.2.1 MEDLINE INDUSTRIES, INC. 325
12.2.2 HOLLISTER INCORPORATED 326
12.2.3 L&R GROUP 327
12.2.4 DERMARITE INDUSTRIES, LLC 328
12.2.5 BIOTISSUE 329
12.2.6 LIFENET HEALTH 330
12.2.7 ADVANCIS MEDICAL 331
12.2.8 HUMAN BIOSCIENCES 332
12.2.9 AMERX HEALTH CARE 333
12.2.10 GENTELL 334
12.2.11 AXIO BIOSOLUTIONS PVT. LTD. 335
13 APPENDIX 336
13.1 DISCUSSION GUIDE 336
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 340
13.3 CUSTOMIZATION OPTIONS 342
13.4 RELATED REPORTS 342
13.5 AUTHOR DETAILS 343

TABLE 1 RISK ASSESSMENT ANALYSIS 46
TABLE 2 AVERAGE COST OF TREATMENT FOR DIABETIC FOOT ULCERS 61
TABLE 3 BIOACTIVE DRESSINGS MARKET: RECENT PRODUCT LAUNCHES 62
TABLE 4 BIOACTIVE DRESSINGS MARKET: RECENT COLLABORATIONS OF NOTE 63
TABLE 5 AVERAGE SELLING PRICE TREND OF BIOACTIVE DRESSINGS,
BY PRODUCT, 2021-2023 65
TABLE 6 AVERAGE SELLING PRICE OF BIOACTIVE DRESSINGS, BY REGION (2023) 66
TABLE 7 BIOACTIVE DRESSINGS MARKET: PORTER'S FIVE FORCES ANALYSIS 75
TABLE 8 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BIOACTIVE DRESSINGS FOR END USERS (%) 76
TABLE 9 KEY BUYING CRITERIA OF BIOACTIVE DRESSINGS FOR END USERS 77
TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 80
TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 80
TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 81
TABLE 13 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81
TABLE 14 IMPORT DATA FOR WADDING, GAUZE, AND BANDAGES, BY COUNTRY,
2019-2023 (USD MILLION) 82
TABLE 15 EXPORT DATA FOR WADDING, GAUZE, AND BANDAGES, BY COUNTRY,
2019-2023 (USD MILLION) 82
TABLE 16 BIOACTIVE DRESSINGS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 84
TABLE 17 BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 90
TABLE 18 BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION) 91
TABLE 19 BIOACTIVE DRESSINGS MARKET, BY REGION, 2022-2029 (USD MILLION) 91
TABLE 20 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 91
TABLE 21 EUROPE: BIOACTIVE DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 92
TABLE 22 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 92
TABLE 23 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 92
TABLE 24 KEY PRODUCTS IN COLLAGEN DRESSINGS SEGMENT 93
TABLE 25 COLLAGEN DRESSINGS MARKET, BY REGION, 2022-2029 (USD MILLION) 94
TABLE 26 NORTH AMERICA: COLLAGEN DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 94
TABLE 27 EUROPE: COLLAGEN DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 95
TABLE 28 ASIA PACIFIC: COLLAGEN DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 95
TABLE 29 LATIN AMERICA: COLLAGEN DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 95
TABLE 30 KEY PRODUCTS IN ALGINATE DRESSINGS SEGMENT 96
TABLE 31 ALGINATE DRESSINGS MARKET, BY REGION, 2022-2029 (USD MILLION) 97
TABLE 32 NORTH AMERICA: ALGINATE DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 97
TABLE 33 EUROPE: ALGINATE DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 98
TABLE 34 ASIA PACIFIC: ALGINATE DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 98
TABLE 35 LATIN AMERICA: ALGINATE DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 98
TABLE 36 KEY PRODUCTS IN CHITOSAN DRESSINGS SEGMENT 99
TABLE 37 CHITOSAN DRESSINGS MARKET, BY REGION, 2022-2029 (USD MILLION) 99
TABLE 38 NORTH AMERICA: CHITOSAN DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 100
TABLE 39 EUROPE: CHITOSAN DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 100
TABLE 40 ASIA PACIFIC: CHITOSAN DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 100
TABLE 41 LATIN AMERICA: CHITOSAN DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 101
TABLE 42 KEY PRODUCTS IN HONEY DRESSINGS SEGMENT 102
TABLE 43 HONEY DRESSINGS MARKET, BY REGION, 2022-2029 (USD MILLION) 102
TABLE 44 NORTH AMERICA: HONEY DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 102
TABLE 45 EUROPE: HONEY DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 103
TABLE 46 ASIA PACIFIC: HONEY DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 103
TABLE 47 LATIN AMERICA: HONEY DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 103
TABLE 48 OTHER BIOACTIVE DRESSINGS MARKET, BY REGION, 2022-2029 (USD MILLION) 105
TABLE 49 NORTH AMERICA: OTHER BIOACTIVE DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 105
TABLE 50 EUROPE: OTHER BIOACTIVE DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 106
TABLE 51 ASIA PACIFIC: OTHER BIOACTIVE DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 106
TABLE 52 LATIN AMERICA: OTHER BIOACTIVE DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 107
TABLE 53 KEY PRODUCTS IN SKIN SUBSTITUTES SEGMENT 108
TABLE 54 SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION) 108
TABLE 55 SKIN SUBSTITUTES MARKET, BY REGION, 2022-2029 (USD MILLION) 109
TABLE 56 NORTH AMERICA: SKIN SUBSTITUTES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 109
TABLE 57 EUROPE: SKIN SUBSTITUTES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 109
TABLE 58 ASIA PACIFIC: SKIN SUBSTITUTES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 110
TABLE 59 LATIN AMERICA: SKIN SUBSTITUTES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 110
TABLE 60 KEY PRODUCTS IN HUMAN DONOR TISSUE-DERIVED PRODUCTS SEGMENT 111
TABLE 61 HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET, BY REGION,
2022-2029 (USD MILLION) 111
TABLE 62 NORTH AMERICA: HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 112
TABLE 63 EUROPE: HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 112
TABLE 64 ASIA PACIFIC: HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 112
TABLE 65 LATIN AMERICA: HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 113
TABLE 66 KEY PRODUCTS IN ACELLULAR ANIMAL-DERIVED PRODUCTS SEGMENT 114
TABLE 67 ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET, BY REGION,
2022-2029 (USD MILLION) 114
TABLE 68 NORTH AMERICA: ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 115
TABLE 69 EUROPE: ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 115
TABLE 70 ASIA PACIFIC: ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 115
TABLE 71 LATIN AMERICA: ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 116
TABLE 72 BIOSYNTHETIC PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION) 116
TABLE 73 NORTH AMERICA: BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 117
TABLE 74 EUROPE: BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 117
TABLE 75 ASIA PACIFIC: BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 117
TABLE 76 LATIN AMERICA: BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 118
TABLE 77 BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION) 120
TABLE 78 KEY PRODUCTS IN NON-ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET 121
TABLE 79 NON-ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY REGION,
2022-2029 (USD MILLION) 121
TABLE 80 NORTH AMERICA: NON-ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 122
TABLE 81 EUROPE: NON-ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 122
TABLE 82 ASIA PACIFIC: NON-ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 122
TABLE 83 LATIN AMERICA: NON-ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 123
TABLE 84 KEY PRODUCTS IN ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET 123
TABLE 85 ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY REGION,
2022-2029 (USD MILLION) 124
TABLE 86 NORTH AMERICA: ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 124
TABLE 87 EUROPE: ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 125
TABLE 88 ASIA PACIFIC: ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 125
TABLE 89 LATIN AMERICA: ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 126
TABLE 90 BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 128
TABLE 91 BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE,
2022-2029 (USD MILLION) 129
TABLE 92 BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY REGION,
2022-2029 (USD MILLION) 129
TABLE 93 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS,
BY COUNTRY, 2022-2029 (USD MILLION) 129
TABLE 94 EUROPE: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION) 130
TABLE 95 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS,
BY COUNTRY, 2022-2029 (USD MILLION) 130
TABLE 96 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS,
BY COUNTRY, 2022-2029 (USD MILLION) 131
TABLE 97 TOTAL DIABETES-RELATED HEALTHCARE EXPENDITURE IN 2021 132
TABLE 98 NUMBER OF PATIENTS DEVELOPING NEW CASES OF DIABETIC FOOT ULCERS, 2022-2029 (THOUSAND) 132
TABLE 99 BIOACTIVE DRESSINGS MARKET FOR DIABETIC FOOT ULCERS, BY REGION,
2022-2029 (USD MILLION) 133
TABLE 100 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2022-2029 (USD MILLION) 133
TABLE 101 EUROPE: BIOACTIVE DRESSINGS MARKET FOR DIABETIC FOOT ULCERS,
BY COUNTRY, 2022-2029 (USD MILLION) 134
TABLE 102 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR DIABETIC FOOT ULCERS,
BY COUNTRY, 2022-2029 (USD MILLION) 134
TABLE 103 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR DIABETIC FOOT ULCERS,
BY COUNTRY, 2022-2029 (USD MILLION) 135
TABLE 104 BIOACTIVE DRESSINGS MARKET FOR PRESSURE ULCERS, BY REGION,
2022-2029 (USD MILLION) 136
TABLE 105 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR PRESSURE ULCERS,
BY COUNTRY, 2022-2029 (USD MILLION) 136
TABLE 106 EUROPE: BIOACTIVE DRESSINGS MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2022-2029 (USD MILLION) 137
TABLE 107 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR PRESSURE ULCERS,
BY COUNTRY, 2022-2029 (USD MILLION) 137
TABLE 108 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR PRESSURE ULCERS,
BY COUNTRY, 2022-2029 (USD MILLION) 138
TABLE 109 BIOACTIVE DRESSINGS MARKET FOR VENOUS LEG ULCERS, BY REGION,
2022-2029 (USD MILLION) 139
TABLE 110 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR VENOUS LEG ULCERS,
BY COUNTRY, 2022-2029 (USD MILLION) 139
TABLE 111 EUROPE: BIOACTIVE DRESSINGS MARKET FOR VENOUS LEG ULCERS,
BY COUNTRY, 2022-2029 (USD MILLION) 140
TABLE 112 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR VENOUS LEG ULCERS,
BY COUNTRY, 2022-2029 (USD MILLION) 140
TABLE 113 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR VENOUS LEG ULCERS,
BY COUNTRY, 2022-2029 (USD MILLION) 141
TABLE 114 BIOACTIVE DRESSINGS MARKET FOR OTHER CHRONIC WOUNDS, BY REGION, 2022-2029 (USD MILLION) 141
TABLE 115 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR OTHER CHRONIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION) 142
TABLE 116 EUROPE: BIOACTIVE DRESSINGS MARKET FOR OTHER CHRONIC WOUNDS,
BY COUNTRY, 2022-2029 (USD MILLION) 142
TABLE 117 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR OTHER CHRONIC WOUNDS,
BY COUNTRY, 2022-2029 (USD MILLION) 142
TABLE 118 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR OTHER CHRONIC WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION) 143
TABLE 119 BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,
2022-2029 (USD MILLION) 143
TABLE 120 BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY REGION,
2022-2029 (USD MILLION) 144
TABLE 121 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS,
BY COUNTRY, 2022-2029 (USD MILLION) 144
TABLE 122 EUROPE: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION) 145
TABLE 123 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION) 145
TABLE 124 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS,
BY COUNTRY, 2022-2029 (USD MILLION) 146
TABLE 125 BIOACTIVE DRESSINGS MARKET FOR SURGICAL WOUNDS, BY REGION,
2022-2029 (USD MILLION) 147
TABLE 126 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR SURGICAL WOUNDS,
BY COUNTRY, 2022-2029 (USD MILLION) 147
TABLE 127 EUROPE: BIOACTIVE DRESSINGS MARKET FOR SURGICAL WOUNDS, BY COUNTRY, 2022-2029 (USD MILLION) 148
TABLE 128 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR SURGICAL WOUNDS,
BY COUNTRY, 2022-2029 (USD MILLION) 148
TABLE 129 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR SURGICAL WOUNDS,
BY COUNTRY, 2022-2029 (USD MILLION) 149
TABLE 130 BIOACTIVE DRESSINGS MARKET FOR TRAUMATIC WOUNDS, BY REGION,
2022-2029 (USD MILLION) 150
TABLE 131 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR TRAUMATIC WOUNDS,
BY COUNTRY, 2022-2029 (USD MILLION) 150
TABLE 132 EUROPE: BIOACTIVE DRESSINGS MARKET FOR TRAUMATIC WOUNDS,
BY COUNTRY, 2022-2029 (USD MILLION) 151
TABLE 133 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR TRAUMATIC WOUNDS,
BY COUNTRY, 2022-2029 (USD MILLION) 151
TABLE 134 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR TRAUMATIC WOUNDS,
BY COUNTRY, 2022-2029 (USD MILLION) 152
TABLE 135 BIOACTIVE DRESSINGS MARKET FOR BURNS, BY REGION,
2022-2029 (USD MILLION) 153
TABLE 136 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR BURNS, BY COUNTRY, 2022-2029 (USD MILLION) 153
TABLE 137 EUROPE: BIOACTIVE DRESSINGS MARKET FOR BURNS, BY COUNTRY,
2022-2029 (USD MILLION) 154
TABLE 138 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR BURNS, BY COUNTRY,
2022-2029 (USD MILLION) 154
TABLE 139 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR BURNS, BY COUNTRY, 2022-2029 (USD MILLION) 155
TABLE 140 BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION) 157
TABLE 141 TOTAL NUMBER OF HOSPITALS, BY COUNTRY, 2022 158
TABLE 142 BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE,
2022-2029 (USD MILLION) 159
TABLE 143 BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY REGION,
2022-2029 (USD MILLION) 159
TABLE 144 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2022-2029 (USD MILLION) 159
TABLE 145 EUROPE: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2022-2029 (USD MILLION) 160
TABLE 146 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2022-2029 (USD MILLION) 160
TABLE 147 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2022-2029 (USD MILLION) 161
TABLE 148 BIOACTIVE DRESSINGS MARKET FOR INPATIENT SETTINGS, BY REGION,
2022-2029 (USD MILLION) 162
TABLE 149 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR INPATIENT SETTINGS,
BY COUNTRY, 2022-2029 (USD MILLION) 162
TABLE 150 EUROPE: BIOACTIVE DRESSINGS MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION) 163
TABLE 151 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR INPATIENT SETTINGS,
BY COUNTRY, 2022-2029 (USD MILLION) 163
TABLE 152 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR INPATIENT SETTINGS,
BY COUNTRY, 2022-2029 (USD MILLION) 164
TABLE 153 BIOACTIVE DRESSINGS MARKET FOR OUTPATIENT SETTINGS, BY REGION,
2022-2029 (USD MILLION) 165
TABLE 154 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR OUTPATIENT SETTINGS,
BY COUNTRY, 2022-2029 (USD MILLION) 165
TABLE 155 EUROPE: BIOACTIVE DRESSINGS MARKET FOR OUTPATIENT SETTINGS,
BY COUNTRY, 2022-2029 (USD MILLION) 166
TABLE 156 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR OUTPATIENT SETTINGS,
BY COUNTRY, 2022-2029 (USD MILLION) 166
TABLE 157 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR OUTPATIENT SETTINGS,
BY COUNTRY, 2022-2029 (USD MILLION) 167
TABLE 158 BIOACTIVE DRESSINGS MARKET FOR HOME CARE SETTINGS, BY REGION,
2022-2029 (USD MILLION) 168
TABLE 159 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2022-2029 (USD MILLION) 168
TABLE 160 EUROPE: BIOACTIVE DRESSINGS MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2022-2029 (USD MILLION) 169
TABLE 161 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2022-2029 (USD MILLION) 169
TABLE 162 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2022-2029 (USD MILLION) 170
TABLE 163 BIOACTIVE DRESSINGS MARKET FOR LONG-TERM CARE FACILITIES, BY REGION, 2022-2029 (USD MILLION) 171
TABLE 164 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2022-2029 (USD MILLION) 171
TABLE 165 EUROPE: BIOACTIVE DRESSINGS MARKET FOR LONG-TERM CARE FACILITIES,
BY COUNTRY, 2022-2029 (USD MILLION) 172
TABLE 166 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2022-2029 (USD MILLION) 172
TABLE 167 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2022-2029 (USD MILLION) 173
TABLE 168 BIOACTIVE DRESSINGS MARKET FOR OTHER END USERS, BY REGION,
2022-2029 (USD MILLION) 174
TABLE 169 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR OTHER END USERS,
BY COUNTRY, 2022-2029 (USD MILLION) 174
TABLE 170 EUROPE: BIOACTIVE DRESSINGS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION) 175
TABLE 171 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR OTHER END USERS,
BY COUNTRY, 2022-2029 (USD MILLION) 175
TABLE 172 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR OTHER END USERS,
BY COUNTRY, 2022-2029 (USD MILLION) 176
TABLE 173 BIOACTIVE DRESSINGS MARKET, BY REGION, 2022-2029 (USD MILLION) 178
TABLE 174 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 180
TABLE 175 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 181
TABLE 176 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET, BY TYPE,
2022-2029 (USD MILLION) 181
TABLE 177 NORTH AMERICA: SKIN SUBSTITUTES MARKET, BY TYPE,
2022-2029 (USD MILLION) 181
TABLE 178 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,
2022-2029 (USD MILLION) 182
TABLE 179 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 182
TABLE 180 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS,
BY TYPE, 2022-2029 (USD MILLION) 182
TABLE 181 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION) 183
TABLE 182 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET, BY END USER,
2022-2029 (USD MILLION) 183
TABLE 183 NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS,
BY TYPE, 2022-2029 (USD MILLION) 183
TABLE 184 US: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 184
TABLE 185 US: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION) 185
TABLE 186 US: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION) 185
TABLE 187 US: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,
2022-2029 (USD MILLION) 185
TABLE 188 US: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 186
TABLE 189 US: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE,
2022-2029 (USD MILLION) 186
TABLE 190 US: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,
2022-2029 (USD MILLION) 186
TABLE 191 US: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION) 187
TABLE 192 US: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE,
2022-2029 (USD MILLION) 187
TABLE 193 DIABETES INCIDENCE IN CANADA, 2023 VS. 2032 188
TABLE 194 CANADA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 189
TABLE 195 CANADA: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION) 189
TABLE 196 CANADA: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION) 189
TABLE 197 CANADA: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,
2022-2029 (USD MILLION) 190
TABLE 198 CANADA: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 190
TABLE 199 CANADA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION) 190
TABLE 200 CANADA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,
2022-2029 (USD MILLION) 191
TABLE 201 CANADA: BIOACTIVE DRESSINGS MARKET, BY END USER,
2022-2029 (USD MILLION) 191
TABLE 202 CANADA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION) 191
TABLE 203 EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY (% OF GDP) 192
TABLE 204 PREVALENCE OF DIABETES IN EUROPE, 2021 VS. 2045 193
TABLE 205 EUROPE: BIOACTIVE DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 193
TABLE 206 EUROPE: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 193
TABLE 207 EUROPE: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION) 194
TABLE 208 EUROPE: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION) 194
TABLE 209 EUROPE: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,
2022-2029 (USD MILLION) 194
TABLE 210 EUROPE: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 195
TABLE 211 EUROPE: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION) 195
TABLE 212 EUROPE: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,
2022-2029 (USD MILLION) 195
TABLE 213 EUROPE: BIOACTIVE DRESSINGS MARKET, BY END USER,
2022-2029 (USD MILLION) 196
TABLE 214 EUROPE: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION) 196
TABLE 215 GERMANY: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 197
TABLE 216 GERMANY: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION) 198
TABLE 217 GERMANY: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION) 198
TABLE 218 GERMANY: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,
2022-2029 (USD MILLION) 198
TABLE 219 GERMANY: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 199
TABLE 220 GERMANY: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION) 199
TABLE 221 GERMANY: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,
2022-2029 (USD MILLION) 199
TABLE 222 GERMANY: BIOACTIVE DRESSINGS MARKET, BY END USER,
2022-2029 (USD MILLION) 200
TABLE 223 GERMANY: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION) 200
TABLE 224 UK: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 201
TABLE 225 UK: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION) 201
TABLE 226 UK: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION) 202
TABLE 227 UK: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,
2022-2029 (USD MILLION) 202
TABLE 228 UK: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 202
TABLE 229 UK: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE,
2022-2029 (USD MILLION) 203
TABLE 230 UK: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,
2022-2029 (USD MILLION) 203
TABLE 231 UK: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION) 203
TABLE 232 UK: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE,
2022-2029 (USD MILLION) 204
TABLE 233 FRANCE: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 205
TABLE 234 FRANCE: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION) 205
TABLE 235 FRANCE: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION) 205
TABLE 236 FRANCE: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,
2022-2029 (USD MILLION) 206
TABLE 237 FRANCE: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 206
TABLE 238 FRANCE: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION) 206
TABLE 239 FRANCE: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,
2022-2029 (USD MILLION) 207
TABLE 240 FRANCE: BIOACTIVE DRESSINGS MARKET, BY END USER,
2022-2029 (USD MILLION) 207
TABLE 241 FRANCE: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION) 207
TABLE 242 ITALY: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 208
TABLE 243 ITALY: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION) 209
TABLE 244 ITALY: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION) 209
TABLE 245 ITALY: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,
2022-2029 (USD MILLION) 209
TABLE 246 ITALY: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 210
TABLE 247 ITALY: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE,
2022-2029 (USD MILLION) 210
TABLE 248 ITALY: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,
2022-2029 (USD MILLION) 210
TABLE 249 ITALY: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION) 211
TABLE 250 ITALY: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION) 211
TABLE 251 SPAIN: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 212
TABLE 252 SPAIN: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION) 212
TABLE 253 SPAIN: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION) 213
TABLE 254 SPAIN: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,
2022-2029 (USD MILLION) 213
TABLE 255 SPAIN: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 213
TABLE 256 SPAIN: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE,
2022-2029 (USD MILLION) 214
TABLE 257 SPAIN: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,
2022-2029 (USD MILLION) 214
TABLE 258 SPAIN: BIOACTIVE DRESSINGS MARKET, BY END USER,
2022-2029 (USD MILLION) 214
TABLE 259 SPAIN: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION) 215
TABLE 260 REST OF EUROPE: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 215
TABLE 261 REST OF EUROPE: BIOACTIVE DRESSINGS MARKET, BY TYPE,
2022-2029 (USD MILLION) 216
TABLE 262 REST OF EUROPE: SKIN SUBSTITUTES MARKET, BY TYPE,
2022-2029 (USD MILLION) 216
TABLE 263 REST OF EUROPE: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,
2022-2029 (USD MILLION) 216
TABLE 264 REST OF EUROPE: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 217
TABLE 265 REST OF EUROPE: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS,
BY TYPE, 2022-2029 (USD MILLION) 217
TABLE 266 REST OF EUROPE: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION) 217
TABLE 267 REST OF EUROPE: BIOACTIVE DRESSINGS MARKET, BY END USER,
2022-2029 (USD MILLION) 218
TABLE 268 REST OF EUROPE: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS,
BY TYPE, 2022-2029 (USD MILLION) 218
TABLE 269 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 220
TABLE 270 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 220
TABLE 271 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY TYPE,
2022-2029 (USD MILLION) 220
TABLE 272 ASIA PACIFIC: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION) 221
TABLE 273 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,
2022-2029 (USD MILLION) 221
TABLE 274 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 221
TABLE 275 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION) 222
TABLE 276 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION) 222
TABLE 277 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY END USER,
2022-2029 (USD MILLION) 222
TABLE 278 ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS,
BY TYPE, 2022-2029 (USD MILLION) 223
TABLE 279 CHINA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 224
TABLE 280 CHINA: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION) 224
TABLE 281 CHINA: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION) 224
TABLE 282 CHINA: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,
2022-2029 (USD MILLION) 225
TABLE 283 CHINA: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 225
TABLE 284 CHINA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE,
2022-2029 (USD MILLION) 225
TABLE 285 CHINA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,
2022-2029 (USD MILLION) 226
TABLE 286 CHINA: BIOACTIVE DRESSINGS MARKET, BY END USER,
2022-2029 (USD MILLION) 226
TABLE 287 CHINA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION) 226
TABLE 288 JAPAN: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 227
TABLE 289 JAPAN: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION) 228
TABLE 290 JAPAN: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION) 228
TABLE 291 JAPAN: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,
2022-2029 (USD MILLION) 228
TABLE 292 JAPAN: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 229
TABLE 293 JAPAN: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE,
2022-2029 (USD MILLION) 229
TABLE 294 JAPAN: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,
2022-2029 (USD MILLION) 229
TABLE 295 JAPAN: BIOACTIVE DRESSINGS MARKET, BY END USER,
2022-2029 (USD MILLION) 230
TABLE 296 JAPAN: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION) 230
TABLE 297 INDIA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 231
TABLE 298 INDIA: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION) 231
TABLE 299 INDIA: SKIN SUBSTITUTES MARKET, TYPE, 2022-2029 (USD MILLION) 232
TABLE 300 INDIA: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,
2022-2029 (USD MILLION) 232
TABLE 301 INDIA: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 232
TABLE 302 INDIA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE,
2022-2029 (USD MILLION) 233
TABLE 303 INDIA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,
2022-2029 (USD MILLION) 233
TABLE 304 INDIA: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022-2029 (USD MILLION) 233
TABLE 305 INDIA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION) 234

TABLE 306 REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 235
TABLE 307 REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY TYPE,
2022-2029 (USD MILLION), 235
TABLE 308 REST OF ASIA PACIFIC: SKIN SUBSTITUTES MARKET, BY TYPE,
2022-2029 (USD MILLION) 235
TABLE 309 REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION) 236
TABLE 310 REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 236
TABLE 311 REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION) 236
TABLE 312 REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS,
BY TYPE, 2022-2029 (USD MILLION) 237
TABLE 313 REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY END USER,
2022-2029 (USD MILLION) 237
TABLE 314 REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION) 237
TABLE 315 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 238
TABLE 316 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 239
TABLE 317 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY TYPE,
2022-2029 (USD MILLION) 239
TABLE 318 LATIN AMERICA: SKIN SUBSTITUTES MARKET, TYPE, 2022-2029 (USD MILLION) 239
TABLE 319 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,
2022-2029 (USD MILLION) 240
TABLE 320 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 240
TABLE 321 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS,
BY TYPE, 2022-2029 (USD MILLION) 240
TABLE 322 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION) 241
TABLE 323 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY END USER,
2022-2029 (USD MILLION) 241
TABLE 324 LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS,
BY TYPE, 2022-2029 (USD MILLION) 241
TABLE 325 BRAZIL: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 242
TABLE 326 BRAZIL: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION) 243
TABLE 327 BRAZIL: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION) 243
TABLE 328 BRAZIL: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,
2022-2029 (USD MILLION) 243
TABLE 329 BRAZIL: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 244
TABLE 330 BRAZIL: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE,
2022-2029 (USD MILLION) 244
TABLE 331 BRAZIL: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,
2022-2029 (USD MILLION) 244
TABLE 332 BRAZIL: BIOACTIVE DRESSINGS MARKET, BY END USER,
2022-2029 (USD MILLION) 245
TABLE 333 BRAZIL: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION) 245
TABLE 334 MEXICO: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 246
TABLE 335 MEXICO: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022-2029 (USD MILLION) 246
TABLE 336 MEXICO: SKIN SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION) 246
TABLE 337 MEXICO: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,
2022-2029 (USD MILLION) 247
TABLE 338 MEXICO: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 247
TABLE 339 MEXICO: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION) 247
TABLE 340 MEXICO: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,
2022-2029 (USD MILLION) 248
TABLE 341 MEXICO: BIOACTIVE DRESSINGS MARKET, BY END USER,
2022-2029 (USD MILLION) 248
TABLE 342 MEXICO: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION) 248
TABLE 343 REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 249
TABLE 344 REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY TYPE,
2022-2029 (USD MILLION) 249
TABLE 345 REST OF LATIN AMERICA: SKIN SUBSTITUTES MARKET, BY TYPE,
2022-2029 (USD MILLION) 250
TABLE 346 REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION) 250
TABLE 347 REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 250
TABLE 348 REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION) 251
TABLE 349 REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION) 251
TABLE 350 REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY END USER,
2022-2029 (USD MILLION) 251
TABLE 351 REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION) 252
TABLE 352 DIABETES IN MIDDLE EAST & NORTH AFRICA, 2021 253
TABLE 353 MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 253
TABLE 354 MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET, BY TYPE,
2022-2029 (USD MILLION) 253
TABLE 355 MIDDLE EAST & AFRICA: SKIN SUBSTITUTES MARKET, BY TYPE,
2022-2029 (USD MILLION) 254
TABLE 356 MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022-2029 (USD MILLION) 254
TABLE 357 MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 254
TABLE 358 MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022-2029 (USD MILLION) 255
TABLE 359 MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS,
BY TYPE, 2022-2029 (USD MILLION) 255
TABLE 360 MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET, BY END USER,
2022-2029 (USD MILLION) 255
TABLE 361 MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022-2029 (USD MILLION) 256
TABLE 362 GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 257
TABLE 363 GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET, BY TYPE,
2022-2029 (USD MILLION) 257
TABLE 364 GCC COUNTRIES: SKIN SUBSTITUTES MARKET, BY TYPE,
2022-2029 (USD MILLION) 257
TABLE 365 GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,
2022-2029 (USD MILLION) 258
TABLE 366 GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 258
TABLE 367 GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS,
BY TYPE, 2022-2029 (USD MILLION) 258
TABLE 368 GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022-2029 (USD MILLION) 259
TABLE 369 GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET, BY END USER,
2022-2029 (USD MILLION) 259
TABLE 370 GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS,
BY TYPE, 2022-2029 (USD MILLION) 259
TABLE 371 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN BIOACTIVE DRESSINGS MARKET 261
TABLE 372 BIOACTIVE DRESSINGS MARKET: DEGREE OF COMPETITION 264
TABLE 373 BIOACTIVE DRESSINGS MARKET RANKING, BY KEY PLAYER, 2023 265
TABLE 374 GLOBAL SKIN SUBSTITUTES MARKET RANKING, BY KEY PLAYER, 2023 266
TABLE 375 BIOACTIVE DRESSINGS MARKET: PRODUCT FOOTPRINT 268
TABLE 376 BIOACTIVE DRESSINGS MARKET: PROPERTY FOOTPRINT 268
TABLE 377 BIOACTIVE DRESSINGS MARKET: APPLICATION FOOTPRINT 269
TABLE 378 BIOACTIVE DRESSINGS MARKET: REGION FOOTPRINT 269
TABLE 379 BIOACTIVE DRESSINGS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 272
TABLE 380 BIOACTIVE DRESSINGS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 272
TABLE 381 BIOACTIVE DRESSINGS MARKET: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2021-JULY 2024 274
TABLE 382 BIOACTIVE DRESSINGS MARKET: DEALS, JANUARY 2021-JULY 2024 275
TABLE 383 BIOACTIVE DRESSINGS MARKET: EXPANSIONS, JANUARY 2021-JULY 2024 276
TABLE 384 BIOACTIVE DRESSINGS MARKET: OTHER DEVELOPMENTS,
JANUARY 2021-JULY 2024 276
TABLE 385 SMITH+NEPHEW: COMPANY OVERVIEW 277
TABLE 386 SMITH+NEPHEW: PRODUCTS OFFERED 278
TABLE 387 SMITH+NEPHEW: EXPANSIONS, JANUARY 2021-JULY 2024 279
TABLE 388 SMITH+NEPHEW: OTHER DEVELOPMENTS, JANUARY 2021-JULY 2024 280
TABLE 389 ORGANOGENESIS INC.: COMPANY OVERVIEW 281
TABLE 390 ORGANOGENESIS INC.: PRODUCTS OFFERED 282
TABLE 391 ORGANOGENESIS INC.: PRODUCT APPROVALS, JANUARY 2021-JULY 2024 283
TABLE 392 ORGANOGENESIS INC.: OTHER DEVELOPMENTS, JANUARY 2021-JULY 2024 284
TABLE 393 MIMEDX GROUP, INC.: COMPANY OVERVIEW 285
TABLE 394 MIMEDX GROUP, INC.: PRODUCTS OFFERED 286
TABLE 395 MIMEDX GROUP, INC.: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2021-JULY 2024 287
TABLE 396 MIMEDX GROUP, INC.: DEALS, JANUARY 2021-JULY 2024 287
TABLE 397 3M: COMPANY OVERVIEW 289
TABLE 398 3M: PRODUCTS OFFERED 290
TABLE 399 3M: OTHER DEVELOPMENTS, JANUARY 2021-JULY 2024 292
TABLE 400 CARDINAL HEALTH: COMPANY OVERVIEW 293
TABLE 401 CARDINAL HEALTH: PRODUCTS OFFERED 294
TABLE 402 B. BRAUN SE: COMPANY OVERVIEW 297
TABLE 403 B. BRAUN SE: PRODUCTS OFFERED 299
TABLE 404 MOLNLYCKE AB: COMPANY OVERVIEW 300
TABLE 405 MOLNLYCKE AB: PRODUCTS OFFERED 301
TABLE 406 CONVATEC INC.: COMPANY OVERVIEW 302
TABLE 407 CONVATEC INC.: PRODUCTS OFFERED 303
TABLE 408 CONVATEC INC.: PRODUCT APPROVALS, JANUARY 2021-JULY 2024 305
TABLE 409 CONVATEC INC.: DEALS, JANUARY 2021-JULY 2024 305
TABLE 410 PAUL HARTMANN AG: COMPANY OVERVIEW 306
TABLE 411 PAUL HARTMANN AG: PRODUCTS OFFERED 307
TABLE 412 COLOPLAST CORP.: COMPANY OVERVIEW 309
TABLE 413 COLOPLAST CORP.: PRODUCTS OFFERED 310
TABLE 414 COLOPLAST CORP.: DEALS, JANUARY 2021-JULY 2024 311
TABLE 415 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW 312
TABLE 416 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED 313
TABLE 417 INTEGRA LIFESCIENCES CORPORATION: DEALS, JANUARY 2021-JULY 2024 316
TABLE 418 ESSITY AKTIEBOLAG: COMPANY OVERVIEW 317
TABLE 419 ESSITY AKTIEBOLAG: PRODUCTS OFFERED 318
TABLE 420 ESSITY AKTIEBOLAG: PRODUCT LAUNCHES, JANUARY 2021-JULY 2024 319
TABLE 421 ESSITY AKTIEBOLAG: DEALS, JANUARY 2021-JULY 2024 319
TABLE 422 COVALON TECHNOLOGIES LTD.: COMPANY OVERVIEW 320
TABLE 423 COVALON TECHNOLOGIES LTD.: PRODUCTS OFFERED 321
TABLE 424 COVALON TECHNOLOGIES LTD.: OTHER DEVELOPMENTS,
JANUARY 2021-JULY 2024 321
TABLE 425 SANARA MEDTECH: COMPANY OVERVIEW 322
TABLE 426 SANARA MEDTECH: PRODUCTS OFFERED 323
TABLE 427 SANARA MEDTECH: PRODUCT LAUNCHES, JANUARY 2021-JULY 2024 324
TABLE 428 SANARA MEDTECH: DEALS, JANUARY 2021-JULY 2024 324
TABLE 429 MEDLINE INDUSTRIES, INC.: COMPANY OVERVIEW 325
TABLE 430 HOLLISTER INCORPORATED: COMPANY OVERVIEW 326
TABLE 431 L&R GROUP: COMPANY OVERVIEW 327
TABLE 432 DERMARITE INDUSTRIES, LLC: COMPANY OVERVIEW 328
TABLE 433 BIOTISSUE: COMPANY OVERVIEW 329
TABLE 434 LIFENET HEALTH: COMPANY OVERVIEW 330
TABLE 435 ADVANCIS MEDICAL: COMPANY OVERVIEW 331
TABLE 436 HUMAN BIOSCIENCES: COMPANY OVERVIEW 332
TABLE 437 AMERX HEALTH CARE: COMPANY OVERVIEW 333
TABLE 438 GENTELL: COMPANY OVERVIEW 334
TABLE 439 AXIO BIOSOLUTIONS PVT. LTD.: COMPANY OVERVIEW 335